NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

IndexS&P 500 P/E- EPS (ttm)-3.26 Insider Own1.61% Shs Outstand255.70M Perf Week-5.97%
Market Cap18.85B Forward P/E16.32 EPS next Y4.52 Insider Trans1.87% Shs Float251.67M Perf Month-5.38%
Enterprise Value28.18B PEG- EPS next Q1.12 Inst Own94.73% Short Float2.12% Perf Quarter-7.59%
Income-835.00M P/S1.65 EPS this Y-1.77% Inst Trans1.92% Short Ratio3.06 Perf Half Y-15.44%
Sales11.43B P/B1.43 EPS next Y6.68% ROA-2.83% Short Interest5.34M Perf YTD-12.84%
Book/sh51.53 P/C30.75 EPS next 5Y4.85% ROE-6.08% 52W Range65.85 - 106.77 Perf Year-22.27%
Cash/sh2.40 P/FCF33.13 EPS past 3/5Y-4.88% -24.99% ROIC-3.92% 52W High-30.98% Perf 3Y-37.11%
Dividend Est.1.65 (2.24%) EV/EBITDA12.59 Sales past 3/5Y-0.49% 17.44% Gross Margin31.04% 52W Low11.91% Perf 5Y-42.13%
Dividend TTM1.60 (2.17%) EV/Sales2.47 EPS Y/Y TTM66.69% Oper. Margin10.68% Volatility1.40% 1.64% Perf 10Y-33.21%
Dividend Ex-DateJun 20, 2025 Quick Ratio1.39 Sales Y/Y TTM0.68% Profit Margin-7.31% RSI (14)40.29 Recom1.81
Dividend Gr. 3/5Y-19.96% -11.58% Current Ratio1.87 EPS Q/Q-1796.50% SMA20-3.65% Beta1.08 Target Price89.00
Payout168.56% Debt/Eq0.75 Sales Q/Q-1.93% SMA50-2.91% Rel Volume2.09 Prev Close74.89
Employees22400 LT Debt/Eq0.62 EarningsMay 06 AMC SMA200-14.68% Avg Volume1.75M Price73.69
IPOMar 02, 1964 Option/ShortYes / Yes EPS/Sales Surpr.5.76% 0.45% Trades Volume3,649,487 Change-1.60%
Date Action Analyst Rating Change Price Target Change
Jun-04-25Initiated Tigress Financial Buy $105
May-08-25Upgrade Barclays Equal Weight → Overweight $84
Feb-20-25Downgrade CFRA Buy → Sell $77
Jan-07-25Upgrade Argus Hold → Buy
Nov-12-24Upgrade Morgan Stanley Equal-Weight → Overweight $111 → $110
Nov-08-24Upgrade BofA Securities Neutral → Buy $107
Nov-07-24Upgrade Vertical Research Hold → Buy $109
Sep-11-24Reiterated Oppenheimer Outperform $116 → $117
Sep-03-24Upgrade Mizuho Neutral → Outperform $109 → $120
Jul-22-24Upgrade Stifel Hold → Buy $95 → $115
Jun-17-25 02:37PM
Jun-11-25 11:30AM
Jun-09-25 05:46PM
Jun-04-25 11:00AM
May-30-25 08:44AM
09:36AM Loading…
May-29-25 09:36AM
May-23-25 09:03AM
May-16-25 05:17PM
06:30AM
May-13-25 09:16AM
May-09-25 08:00AM
May-08-25 03:15AM
12:10AM
May-07-25 05:19PM
12:13PM
12:03PM Loading…
12:03PM
12:03PM
11:21AM
May-06-25 06:00PM
05:30PM
04:20PM
May-02-25 10:56AM
09:10AM
May-01-25 06:00PM
04:15PM
12:18PM
09:15AM
02:00AM
Apr-29-25 10:01AM
Apr-28-25 05:00PM
08:00AM Loading…
08:00AM
Apr-23-25 08:21PM
Apr-22-25 02:00AM
Apr-16-25 08:54AM
12:00AM
Apr-14-25 04:15PM
09:02AM
Apr-10-25 09:11AM
08:00AM
Apr-09-25 08:00AM
Apr-08-25 07:23PM
08:00AM
Apr-03-25 03:30PM
01:43PM
Apr-01-25 03:00AM
Mar-30-25 08:41AM
Mar-27-25 04:45PM
02:00AM
Mar-24-25 07:00PM
01:24PM
Mar-20-25 11:30AM
Mar-10-25 08:00PM
Mar-05-25 04:15PM
Mar-03-25 12:37AM
Feb-27-25 02:54PM
Feb-25-25 07:00AM
Feb-21-25 05:22AM
Feb-20-25 05:11PM
04:30PM
02:06AM
01:06AM
Feb-19-25 03:57PM
Feb-18-25 06:00PM
05:25PM
04:25PM
04:15PM
Feb-13-25 04:00PM
09:15AM
Feb-11-25 10:00AM
Feb-06-25 04:03PM
Feb-05-25 07:31AM
Feb-04-25 02:00AM
Jan-29-25 09:39AM
Jan-23-25 04:24PM
Jan-15-25 08:00AM
Jan-14-25 08:00AM
Jan-08-25 08:00AM
Dec-19-24 04:15PM
Dec-12-24 08:00AM
Dec-10-24 04:15PM
Dec-05-24 11:30AM
Dec-02-24 08:48AM
Nov-20-24 12:36PM
Nov-14-24 04:00AM
Nov-12-24 12:13AM
Nov-11-24 09:15AM
Nov-08-24 12:56PM
Nov-07-24 02:01PM
09:35AM
Nov-06-24 04:43PM
12:52PM
12:01AM
Nov-05-24 06:00PM
05:25PM
04:32PM
04:15PM
Nov-04-24 04:00AM
Oct-31-24 09:15AM
Oct-30-24 04:15PM
Oct-29-24 10:01AM
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world's finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Teles de Mendonca Ana PaulaPresident, ScentJun 02 '25Option Exercise0.0064303,088Jun 04 05:38 PM
Arora YuvrajPresident, Taste & CCOMay 05 '25Option Exercise0.0017,309022,291Jun 04 05:27 PM
Arora YuvrajPresident, Taste & CCOMay 01 '25Option Exercise0.003,57206,810Jun 04 05:27 PM
O'Byrne KevinDirectorMay 22 '25Buy76.054,500342,2407,696May 23 04:46 PM
Teles de Mendonca Ana PaulaPresident, ScentMay 05 '25Option Exercise0.001,49803,210May 22 07:30 PM
Teles de Mendonca Ana PaulaPresident, ScentMay 01 '25Option Exercise0.001,58702,523May 22 07:30 PM
Palau Hernandez MargaritaDirectorMay 19 '25Buy77.4285065,8072,393May 20 01:33 PM
Yildiz BerilCAO, SVP & ControllerMay 19 '25Sale77.332,400185,6043,321May 19 05:09 PM
Landsman Stephen NEVP, General CounselMay 19 '25Buy77.2812,000927,35612,000May 19 05:08 PM
Yildiz BerilOfficerMay 19 '25Proposed Sale77.332,400185,604May 19 01:12 PM
Yildiz BerilCAO, SVP & ControllerMay 05 '25Option Exercise0.0084906,028May 16 09:01 PM
Yildiz BerilCAO, SVP & ControllerMay 01 '25Option Exercise0.0095205,523May 16 09:01 PM
Finzel RalfEVP, Global Operations OfficerMay 05 '25Option Exercise0.001,32609,976May 16 09:01 PM
Finzel RalfEVP, Global Operations OfficerMay 01 '25Option Exercise0.001,98409,663May 16 09:01 PM
DeVeau MichaelEVP, CFOMay 05 '25Option Exercise0.00884011,048May 16 09:01 PM
DeVeau MichaelEVP, CFOMay 01 '25Option Exercise0.001,389010,874May 16 09:01 PM
Borg DeborahEVP, Chief Ppl&Culture OfficerMay 05 '25Option Exercise0.001,768028,383May 16 09:00 PM
Borg DeborahEVP, Chief Ppl&Culture OfficerMay 01 '25Option Exercise0.002,381027,817May 16 09:00 PM
Palau Hernandez MargaritaDirectorMay 01 '25Option Exercise0.001,54301,543May 16 08:57 PM
O'Byrne KevinDirectorMay 01 '25Option Exercise0.001,87503,590May 16 08:56 PM
Khan MehmoodDirectorMay 15 '25Buy75.334,000301,3144,604May 15 05:27 PM
Fyrwald J ErikChief Executive OfficerMay 09 '25Buy73.9724,3001,797,45662,070May 09 05:03 PM
Fyrwald J ErikChief Executive OfficerMay 08 '25Buy74.0070051,79737,770May 09 05:03 PM
JAMISON CYNTHIA TDirectorMay 01 '25Option Exercise0.006040604May 05 05:51 PM
INTRIERI VINCENT JDirectorMay 01 '25Option Exercise0.006040604May 05 05:50 PM
Costa Mark JDirectorMay 01 '25Option Exercise0.001,87504,014May 05 05:50 PM
Khan MehmoodDirectorMay 01 '25Option Exercise0.006040604May 05 05:47 PM
Fyrwald J ErikChief Executive OfficerMay 01 '25Option Exercise0.0015,875045,175May 05 05:46 PM
Strzelecki AngelaPresident, Pharma SolutionsApr 04 '25Option Exercise0.001,761010,362Apr 07 04:17 PM
DeVeau MichaelCFOApr 04 '25Option Exercise0.001,993010,204Apr 07 04:16 PM
Borg DeborahEVP, Chief Ppl&Culture OfficerApr 04 '25Option Exercise0.004,602027,981Apr 07 04:16 PM
O'Byrne KevinDirectorMar 05 '25Buy80.446,500522,8336,500Mar 06 05:13 PM
Fyrwald J ErikCEOMar 04 '25Buy80.2425,0002,005,87829,300Mar 05 04:08 PM
Finzel RalfEVP, Global Operations OfficerDec 02 '24Option Exercise0.005,38709,622Dec 03 04:05 PM
Arora YuvrajPresident, NourishNov 11 '24Sale91.755,000458,7753,238Nov 12 04:20 PM
Arora YuvrajOfficerNov 11 '24Proposed Sale91.755,000458,775Nov 12 09:07 AM
RICHTER GLENN RCFOOct 01 '24Option Exercise0.0011,812032,171Oct 03 04:20 PM
Borg DeborahEVP, Chief HR and D&I OfficerSep 03 '24Option Exercise0.0013,807030,282Sep 05 04:05 PM
Herriott SimonPres. Health & BioscienceJul 03 '24Option Exercise0.00627010,759Jul 05 04:10 PM